These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 1639960)
1. A direct immunoradiometric assay for human plasma prorenin: concentrations in cycling women and in women taking oral contraceptives. Schumacher M; Nanninga A; Delfs T; Mukhopadhyay AK; Leidenberger FA J Clin Endocrinol Metab; 1992 Aug; 75(2):617-23. PubMed ID: 1639960 [TBL] [Abstract][Full Text] [Related]
2. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. Derkx FH; Steunkel C; Schalekamp MP; Visser W; Huisveld IH; Schalekamp MA J Clin Endocrinol Metab; 1986 Oct; 63(4):1008-15. PubMed ID: 3528208 [TBL] [Abstract][Full Text] [Related]
3. Pulsatile luteinizing hormone patterns in long term oral contraceptive users. Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046 [TBL] [Abstract][Full Text] [Related]
4. [Immunoradiometric assay for active renin and plasma prorenin during cycles stimulated by IVFET or GIFT]. Guichard A; Mignot TM; Boyer P; Zorn JR; Cedard L Reprod Nutr Dev (1980); 1988; 28(6B):1731-40. PubMed ID: 3150115 [TBL] [Abstract][Full Text] [Related]
5. Changes in insulin receptors during oral contraception. De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643 [TBL] [Abstract][Full Text] [Related]
6. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures. Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130 [TBL] [Abstract][Full Text] [Related]
7. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629 [TBL] [Abstract][Full Text] [Related]
8. High concentrations of immunoreactive renin, prorenin and enzymatically-active renin in human ovarian follicular fluid. Derkx FH; Alberda AT; Zeilmaker GH; Schalekamp MA Br J Obstet Gynaecol; 1987 Jan; 94(1):4-9. PubMed ID: 3545283 [TBL] [Abstract][Full Text] [Related]
9. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during menstrual cycles controlled by oral contraceptive preparations. Johnson IR Br J Obstet Gynaecol; 1980 Oct; 87(10):883-8. PubMed ID: 7000163 [TBL] [Abstract][Full Text] [Related]
10. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women. Weinberger MH; Kramer NJ; Grim CE; Petersen LP J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263 [TBL] [Abstract][Full Text] [Related]
11. Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents. Gordon EM; Douglas J; Ratnoff OD J Clin Invest; 1983 Nov; 72(5):1833-8. PubMed ID: 6355187 [TBL] [Abstract][Full Text] [Related]
12. A novel assay of plasma prorenin using a renin inhibitor. Derkx FH; de Bruin RJ; van Gool JM; Rosmalen FM; van Hoek MJ; Beerendonk CC; Schalekamp MA J Hypertens Suppl; 1993 Dec; 11(5):S240-1. PubMed ID: 8158364 [No Abstract] [Full Text] [Related]
13. Serum levels of relaxin during the menstrual cycle and oral contraceptive use. Wreje U; Kristiansson P; Aberg H; Byström B; von Schoultz B Gynecol Obstet Invest; 1995; 39(3):197-200. PubMed ID: 7789917 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a direct prorenin assay making use of a monoclonal antibody directed against residues 32-39 of the prosegment. Krop M; van Gool JM; Day D; Hollenberg NK; Jan Danser AH J Hypertens; 2011 Nov; 29(11):2138-46. PubMed ID: 21881521 [TBL] [Abstract][Full Text] [Related]
15. Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle. Sealey JE; Cholst I; Glorioso N; Troffa C; Weintraub ID; James G; Laragh JH J Clin Endocrinol Metab; 1987 Jul; 65(1):1-5. PubMed ID: 3294878 [TBL] [Abstract][Full Text] [Related]
16. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives. Hayashi M; Saruta T; Nakamura R; Saito I; Kondo K; Kato E Gynecol Obstet Invest; 1979; 10(5):246-53. PubMed ID: 395034 [TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis, renin activity, and prorenin in normal women: effects of exercise and oral contraceptive medication. Hedlin AM; Loh AY; Osmond DH J Clin Endocrinol Metab; 1979 Nov; 49(5):663-71. PubMed ID: 158599 [TBL] [Abstract][Full Text] [Related]
18. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II/Angiotensin (1-7) ratio and 24-h blood pressure throughout the menstrual cycle and in women using oral contraceptives. Davis GC; Gibson KJ; Casley D; Brown MA J Hypertens; 2017 Jun; 35(6):1178-1186. PubMed ID: 28234675 [TBL] [Abstract][Full Text] [Related]
20. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. Garnero P; Grimaux M; Demiaux B; Preaudat C; Seguin P; Delmas PD J Bone Miner Res; 1992 Dec; 7(12):1389-98. PubMed ID: 1481725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]